Technology transfer model for the formulation stage in biological products for public health

Main Article Content

Jorge L Magalhães*
Alessandra L Viçosa
Giselle Ribeiro de Barros

Abstract

Technology transfer is a tool used to absorb knowledge and technology, in addition to increasing a country’s technological innovation. In the health sector, it is no different, especially in times of outbreaks, epidemics and global pandemic. Therefore, tools that assist in the creation of public policies contribute to the research, development and innovation of new technologies to produce vaccines and medicines. Thus, it proposes a universal technology transfer model based on International guides from the World Health Organization, Parenteral Drugs Association and the International Society of Pharmaceutical Engineering. It was concluded that the model ensures reliability between the parties and promotes a dynamic and rapid methodology for application in public health in the country.

Downloads

Download data is not yet available.

Article Details

Magalhães, J. L., Viçosa, A. L., & de Barros, G. R. (2020). Technology transfer model for the formulation stage in biological products for public health. Archives of Community Medicine and Public Health, 6(1), 084–087. https://doi.org/10.17352/2455-5479.000084
Mini Reviews

Copyright (c) 2020 Magalhães JL, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

IQVIA (2018) Channel Dynamics Global Reference 2018. Link: https://bit.ly/2Xuzqmr

Magalhães JL (2011) Laboratórios farmacêuticos oficiais e sua relevância para saúde pública do Brasil. Reciis 5: 85–99. Link: https://bit.ly/2ywHASL

Mohite PB, Sangle SV, Bhusan B, Nautiyal U, Kumar S, et al. (2017) Technology transfer in Pharmaceutical Industry: A review. International Journal of Advances in Pharmaceutics 6: 1–7.

WHO (2011) Annex 7 WHO guidelines on transfer of technology. WHO Technical Report 961: 285–309. Link: https://bit.ly/2Zz4C6J

Brekke OH, Sandlie I (2003) Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2: 52–62. Link: https://bit.ly/2AWfcKE

Moon S, Bermudez J, ’t Hoen E (2012) Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System? PLoS Med 9: e1001218. Link: https://bit.ly/3ekCh8q

World Health Organization (2016) WHO | Sixty-ninth World Health Assembly. Switzerland. Link: https://bit.ly/3gq1G22

Alam MS, Ahmad J (2013) Pharmaceutical Technology Transfer: An Overview. International Journal of Pharmaceutical Sciences and Research IJPSR 4: 2441–2449. Link: https://bit.ly/36sTyJO

Kumar V, Kumar U, Persaud A (1999) Building technological capability through importing technology: The case of Indonesian manufacturing industry. Journal of Technology Transfer 24: 81-96. Link: https://bit.ly/2TGRg4F

PDA (2014) Technical Report No 65 Technology Transfer. 1. Link: https://bit.ly/2A5h5Eu

Campos ALN (2014) Modelagem de Processos com BPMN (Brasport, Org.; 2a edição).

Magalhães J, Hartz Z, Temido M, Antunes A (2018) Gestão do conhecimento em tempos de big data: um olhar dos desafios para os sistemas de saúde. Anais 17. Link: https://bit.ly/3gmWigm

HO PL, Miyaji EN, Oliveira MLS, Dias WO, Kubrusly FS, et al. (2011) Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil. Link: https://bit.ly/3d2yV9D